REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.10
Bid: 44.10
Ask: 45.90
Change: 0.00 (0.00%)
Spread: 1.80 (4.082%)
Open: 44.10
High: 44.10
Low: 44.10
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Renewal of Sales and Marketing Agreement

22 Aug 2017 07:00

RNS Number : 6013O
Benchmark Holdings PLC
22 August 2017
 

 

Benchmark Holdings plc("Benchmark" or the "Company")

 

Benchmark secures renewal of key strategic sales and marketing agreement with Great Salt Lake artemia cooperative

 

Benchmark announces that its wholly owned subsidiary, INVE Aquaculture Holding BV (INVE), has successfully renewed its sales and marketing agreement with the Great Salt Lake Brine Shrimp Cooperative, Inc (GSL COOP). Under this long-term agreement, the Benchmark group maintains its rights to distribute a substantial share of the GSL COOP's harvest of artemia from the Great Salt Lake, Utah, the world's greatest source of brine shrimp, a natural live food widely used by the aquaculture industry in early stage nutrition.

 

Historically, artemia supplied under the sales and marketing agreement has represented approximately 60% of INVE's total artemia sales, and generated revenues of over £30m in 2016. The renewal of the sales and marketing agreement secures the Company long-term access to the world's top quality artemia, which, as well as providing significant revenues from direct sales, creates demand pull for INVE's portfolio of aquaculture hatchery feeds and health products.

 

Alongside continuation of the sales and marketing agreement, INVE has entered into a similarly long-term distribution agreement with the GSL COOP for INVE's current and future artemia-related products and technologies. INVE is developing a range of breakthrough artemia-related feed products, which are on track to be launched in early 2020. The distribution agreement with the GSL COOP provides Benchmark with access to additional distribution channels and customers for INVE's artemia-related products, and will contribute to growth in sales from 2020 onwards.

 

Both the sales and marketing agreement and the distribution agreement have an initial 10 year term. Under the sales and marketing agreement GSL COOP has a 5 year break clause in certain circumstances related to new product development.

 

Benchmark CEO Malcolm Pye commented:

 

"We are extremely pleased to be continuing with and building on our important relationship with the GSL COOP. The sales and marketing agreement secures long-term access to the best quality artemia available globally, from a responsibly and sustainably harvested source. Access to the GSL COOP's customer base will compliment Benchmark's existing distribution networks for its developing artemia-related product portfolio, and is expected to create significant growth in sales across the Advanced Animal Nutrition division in the years to come."

 

 

-ENDS-

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

Tavistock

Tel: 020 7920 3150

Niall Walsh / Sophie Praill / Simon Hudson

 

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

 

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping farmers to take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology Benchmark is able to tackle the key issues in the aquaculture, livestock and companion animal sectors.

 

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 30 June 2017, Benchmark employed 951 people. 

 

For further information on Benchmark please visit www.benchmarkplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUUWRUPMUGP
Date   Source Headline
29th Jul 20227:00 amRNSTotal Voting Rights
14th Jul 20227:00 amRNSNotice of Capital Markets Day and Site Visit
1st Jul 202212:08 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSTotal Voting Rights
16th Jun 20224:41 pmRNSSecond Price Monitoring Extn
16th Jun 20224:36 pmRNSPrice Monitoring Extension
1st Jun 20227:00 amRNSConversion of loan into green loan
31st May 20227:00 amRNSTotal Voting Rights
23rd May 20225:15 pmRNSDirector Dealings
20th May 20221:05 pmRNSDirector Dealings
18th May 20227:00 amRNSSecond Quarter and Interim results
3rd May 20227:00 amRNSMarket Authorisation Update
29th Apr 20222:29 pmRNSTotal Voting Rights
28th Apr 20227:00 amRNSNotice of Q2 and Interim Results
21st Apr 20223:17 pmRNSHolding(s) in Company
31st Mar 20227:00 amRNSTotal Voting Rights
21st Mar 20227:00 amRNSBlock Listing Six Monthly Return
28th Feb 20229:15 amRNSTotal Voting Rights
22nd Feb 20227:00 amRNSQ1 Results
10th Feb 20225:37 pmRNSResult of AGM
7th Feb 20227:00 amRNSNotice of Q1 Results
4th Feb 20224:41 pmRNSSecond Price Monitoring Extn
4th Feb 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTotal Voting Rights
20th Jan 20227:00 amRNSHolding(s) in Company
31st Dec 20217:00 amRNSTotal Voting Rights
24th Dec 20217:00 amRNSHolding(s) in Company
13th Dec 20213:46 pmRNSHolding(s) in Company
10th Dec 20214:17 pmRNSPosting of Annual Report and Notice of AGM
8th Dec 202112:02 pmRNSDIRECTOR SHARE OPTIONS
2nd Dec 20215:58 pmRNSAnnual Report available on website
1st Dec 202110:12 amRNSHolding(s) in Company
1st Dec 202110:02 amRNSTotal Voting Rights
29th Nov 20212:38 pmRNSPCA Dealing
29th Nov 202110:50 amRNSANNOUNCEMENT REGARDING DIRECTOR SUBSCRIPTIONS
29th Nov 20217:01 amRNSPlacing and Appointment of non-Executive Director
29th Nov 20217:00 amRNSQ4 Results
29th Nov 20217:00 amRNSFull Year Results
12th Nov 20217:00 amRNSInvestor Presentation covering Full Year Results
29th Oct 20217:00 amRNSTotal Voting Rights
18th Oct 20217:00 amRNSTrading Statement
30th Sep 20217:00 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSEnvironmental recognition for CleanTreat®
21st Sep 20217:00 amRNSBlock Listing Six Monthly Return
31st Aug 20217:00 amRNSTotal Voting Rights
25th Aug 20217:00 amRNSEquity Development Investor Webinar
24th Aug 20217:00 amRNSQ3 Results
30th Jul 20217:00 amRNSTotal Voting Rights
15th Jul 20213:00 pmRNSAdoption of MRL for Ectosan Vet in Norway
2nd Jul 20213:20 pmRNSBMK08+CleanTreat and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.